Retension Pharmaceuticals, Inc. (NASDAQ:RTSN) People

Retension Pharmaceuticals, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Franklin Berger
Other companies: Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Kezar Life Sciences, Inc. (Director · Since at least Jun 25, 2019); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Kineta Inc. (Director · Jun 27, 2019 – Jun 29, 2020 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Five Prime Therapeutics Inc (Director · Jun 10, 2019 – Apr 16, 2021 · Past); Tocagen Inc (Director · May 29, 2019 – Oct 4, 2019 · Past); Immune Design Corp (Director · Apr 2, 2019 – Apr 2, 2019 · Past)
Director · Since at least Oct 13, 2026
Pavan Cheruvu
Other companies: Amanat Acquisition Corp (Chief Executive Officer, Director · Since at least May 18, 2026); Sio Gene Therapies Inc (Chief Executive Officer, Director · Feb 11, 2018 – Dec 8, 2021 · Past)
Director · Since at least Nov 5, 2026
Donald Olds
Other companies: Grace Therapeutics, Inc. (Director · Apr 1, 2020 – Aug 31, 2023 · Past)
Director · Since at least Oct 13, 2026
Michael J Berendt
Other companies: Waters Corporation (Director · May 15, 2013 – Aug 13, 2021 · Past)
Director · Since at least Oct 13, 2026
Alex SchwartzChief Financial Officer · Since at least Nov 4, 2026
Alison D. SchecterChief Medical Officer · Since at least Nov 4, 2026
Eric KellerCHIEF EXECUTIVE OFFICER, Director · Since at least Oct 13, 2026
Kevin SchutzVice President, Regulatory Affairs · Since at least Nov 4, 2026
LeAnne BloedonExecutive Vice President, Clinical Development and Operations · Since at least Nov 4, 2026
Paul SweetnamCHIEF SCIENTIFIC OFFICER · Since at least Oct 13, 2026
Sabine BissonCHIEF OPERATING OFFICER · Since at least Oct 13, 2026